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Abstract
The downstream regulatory element antagonist modulator (DREAM), a multifunctional Ca2+-binding protein, binds
specifically to DNA and several nucleoproteins regulating gene expression and with proteins outside the nucleus
to regulate membrane excitability or calcium homeostasis. DREAM is highly expressed in the central nervous sys-
tem including the hippocampus and cortex; however, the roles of DREAM in hippocampal synaptic transmission
and plasticity have not been investigated. Taking advantage of transgenic mice overexpressing a Ca2+-insensitive
DREAM mutant (TgDREAM), we used integrative methods including electrophysiology, biochemistry, immunostain-
ing, and behavior tests to study the function of DREAM in synaptic transmission, long-term plasticity and fear
memory in hippocampal CA1 region. We found that NMDA receptor but not AMPA receptor-mediated current was
decreased in TgDREAM mice. Moreover, synaptic plasticity, such as long-term depression (LTD) but not long-term
potentiation (LTP), was impaired in TgDREAM mice. Biochemical experiments found that DREAM interacts with
PSD-95 and may inhibit NMDA receptor function through this interaction. Contextual fear memory was significantly
impaired in TgDREAM mice. By contrast, sensory responses to noxious stimuli were not affected. Our results
demonstrate that DREAM plays a novel role in postsynaptic modulation of the NMDA receptor, and contributes to
synaptic plasticity and behavioral memory.
Introduction
Long-term plastic changes in the individual synapses of
the central nervous system are engaged in key physiolo-
gical functions such as neurodevelopment, learning,
memory, fear and emotion, and in many pathological
conditions such as drug abuse, chronic pain, anxiety and
other brain diseases [1-7]. Calcium-dependent signaling
pathways, triggered mainly by several neurotransmitter
receptors and voltage-dependent ion channels, contri-
bute to gene regulation and protein synthesis that are
critical for long-term plastic changes [2,8-10]. The sig-
naling pathways linking calcium increases to gene acti-
vation have been intensively investigated in synaptic
plasticity and behavioral memory. For example, cAMP,
produced by calcium-calmodulin (CaM) activated
adenylyl cyclases (AC) including AC1 and AC8, regu-
lates new gene expression and protein synthesis through
PKA-CREB dependent pathways, and directly or indir-
ectly contributes to long-term potentiation (LTP)
[2,11,12] and memory from invertebrates to vertebrates
[13-18]. Furthermore, calcium-CaM regulated protein
kinases including CaMKII and CaMKIV are also critical
in synaptic plasticity and behavioral memory [19-27].
Both PKA and CaMKIV regulate the activation of CREB
in the nucleus either through the subunit translocation
(in case of PKA) or the entry of CaM (CaMKIV)
[28-30].
In addition to well-known protein kinases and phos-
phatase pathways, postsynaptic calcium also regulates
the transcriptional activity of some repressors [8,31-33].
The DREAM was characterized as a multifunctional Ca2
+ binding protein with defined functions both in and
outside the nucleus. In the nucleus, DREAM binds to
specific downstream regulatory element (DRE) to
* Correspondence: min.zhuo@utoronto.ca
† Contributed equally
1Department of Physiology, Faculty of Medicine, University of Toronto, 1
King’s College Circle, Toronto, Ontario, Canada
Wu et al. Molecular Brain 2010, 3:3
http://www.molecularbrain.com/content/3/1/3
© 2010 Wu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
repress transcription of target genes [34-36]. Outside the
nucleus, DREAM interacts with presenilins or Kv4
potassium channels, to modulate calcium release from
the endoplasmic reticulum [37] or channel gating,
respectively [38,39]. Because of that, DREAM is also
known as calsenilin or potassium channel interacting
protein-3 (KchIP-3) [39,40]. The roles of DREAM in
synaptic plasticity and behavioral learning have been
investigated and the potential phenotype in learning-
related plastic pathways observed in DREAM knock out
mice [35,41,42]. Due to genetic compensation by the
other members of the DREAM/KChIP family, the use of
DREAM/calsenilin knockout mice in the study of synap-
tic transmission, synaptic plasticity and memory could
have compromised the observation of a clear phenotype
[32,33].
In the present study, we used transgenic mice
(TgDREAM) overexpressing a Ca2+- and cAMP-insensi-
tive DREAM mutant, which has been shown to act as a
dominant active mutant specific for DREAM transcrip-
tional repressor function, blocking basal expression of
Na+/Ca2+ exchanger 3 (NCX-3) in the brain [43] and
cytokines in transgenic T cells [44]. By integrating dif-
ferent approaches, including electrophysiology, biochem-
istry and pharmacology, the roles of DREAM in basal
synaptic transmission and long-term plasticity in hippo-
campal CA1 neurons were investigated. We found that
NMDA receptor-mediated synaptic transmission and
plasticity was impaired in TgDREAM mice. Co-immu-
noprecipitation results indicated that DREAM interacts
with PSD-95. Consistently with synaptic findings, the
TgDREAM mice showed impairments in contextual fear
memory. Our results provide strong evidence that
DREAM modulates the function of postsynaptic NMDA
receptor, synaptic plasticity, and behavioral learning and
memory.
Results
To analyze the functional significance of the Ca2
+-dependent transcriptional repressor DREAM proteins,
we used transgenic mice that express the double
DREAM mutant that will block specifically Ca2+ depen-
dent derepression at DRE sites [43] without affecting
CREB-dependent transcription [45]. Quantitative RT-
PCR showed that mutant DREAM is expressed in the
hippocampus, cerebral cortex and cerebellum (Figure
1A). We then analyzed whether mutant DREAM also
interacts physically and forms heterooligomers with
KChIP-1 and -4 proteins. Co-immunoprecipitation of
differentially tagged Ca2+ insensitive mutant DREAM
and DREAM/KChIP proteins (1, 2, 3 and 4) confirmed
the cross-interaction between DREAM and the other
three family members after overexpression in HEK293
cells (Figure 1B). Thus, in the brain the mutant DREAM
is likely interfere with all Ca2+-related transcriptional
responses mediated by DREAM/KChIP proteins. We
also studied the gross anatomy of the brain in transgenic
mice by Cresyl violet staining. Serial coronal sections
were examined and there is no detectable morphological
difference between TgDREAM and wild-type mice in
the anterior cingulate cortex, somatosensory cortex,
insular cortex, amygdale, hippocampus, thalamus, peria-
queductal gray, spinal dorsal horn, or dorsal root ganglia
(Figure 2).
Figure 1 In vivo and in vitro characterization of TgDREAM. (A)
Quantitative real-time RT-PCR of TgDREAM mRNA levels in different
brain areas from transgenic mice. Expression level of the transgene
was corrected by b-actin mRNA level in each ample. (B) Co-
immunoprecipitation of TgDREAM-Flag and DREAM/KChIP Myc-
tagged proteins (1 to 4) after overexpression in HEK293 cells.
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Loss of LTD in TgDREAM mice
As a multifunctional Ca2+-binding protein highly
expressed in neurons, DREAM is an attractive candidate
serving critical roles in brain functions. Few studies,
however, have aimed to address this question, particu-
larly hippocampus-related functions [35,41]. Here we
focused on the functions of DREAM in the synaptic
transmission and plasticity, as well as hippocampus-
related memory. First, we examined the hippocampal
Schaffer collateral pathway in the CA1 region and com-
pared electrophysiological responses in wild-type versus
TgDREAM mice. Experiments were performed by con-
ventional whole-cell patch clamp recordings in visually
identified pyramidal neurons from hippocampal CA1
layer. Evoked excitatory postsynaptic currents (EPSCs)
were obtained by delivering stimuli using a bipolar elec-
trode placed in the stratum radiatum. To induce LTP in
hippocampal CA1 neurons, the pairing protocol invol-
ving holding CA1 neurons at +30 mV paired with 80
pulses of presynaptic stimulation at 2 Hz was used (Fig-
ure 3A). LTP was reliably induced in wild-type mice
(173.1 ± 1.5% of baseline response, n = 6) (Figure 3B
and 3C). Similar LTP was observed in TgDREAM mice
(174.6 ± 1.5% of baseline response, n = 6) (Figure 3B
and 3C), indicating that LTP is not affected in trans-
genic mice.
LTD was then tested in TgDREAM mice. For that,
low frequency synaptic stimuli (1 Hz) paired with CA1
neurons held at -45 mV were used (Figure 3D). LTD
was triggered in wild-type mice (73.0 ± 4.6% of baseline
response, n = 8) (Figure 3E and 3F). In contrast, LTD
was significantly reduced in TgDREAM mice (112.5 ±
6.8% of baseline response, n = 8, P < 0.01 compared
with LTD in wild-type mice) (Figure 3E and 3F). Taken
together, these results indicate that DREAM contributes
selectively to pairing protocol-induced LTD but not
LTP induction in the hippocampal CA1 pyramidal
neurons.
Reduced NMDA receptor-mediated EPSCs in TgDREAM
mice
Pairing protocol-induced LTD in the hippocampal CA1
synapse required postsynaptic Ca2+ elevation through
activation of the NMDA subtype of glutamate receptors.
Therefore, we tested the function of NMDA receptor
complex in TgDREAM mice. Experiments were per-
formed to compare NMDA receptor-mediated EPSCs in
TgDREAM and wild-type mice. Various stimulation
intensities were used and input-output relationship of
NMDA receptor-mediated EPSCs were generated. We
found that the amplitude of NMDA receptor-mediated
EPSCs in TgDREAM mice (n = 7) was significantly
reduced compared with that in wild-type mice (n = 8, P
< 0.05) (Figure 4A).
Functional NMDA receptors in the hippocampal CA1
neurons contain mainly heterogenic combinations of the
NR1 with NR2A or NR2B subunits [46]. Next we
wanted to know the contribution of NR2A and NR2B to
the reduction of NMDA receptor-mediated currents in
TgDREAM mice. For that, pharmacological antagonists
for NR2A or NR2B were used. Bath application of NVP-
AAM077 (0.4 μM), a relatively selective NR2A subunit
antagonist, blocked NMDA receptor-mediated EPSCs by
64.4 ± 8.3% (n = 7) in wild-type mice and by 63.2 ±
10.7% (n = 7) in TgDREAM mice (Figure 4B). Following
the addition of ifenprodil (3 μM), a selective antagonist
Figure 2 Normal brain morphology in TgDREAM mice. Coronal
sections showed no detectable morphological differences in the
anterior cingulate cortex, somatosensory cortex, insular cortex,
amygdala, hippocampus, thalamus, periaqueductal gray (PAG), spinal
cord dorsal horn as well as dorsal root ganglia. Scale bar: 250 μm
(cortex, amygdala and PAG), 500 μm (hippocampus and thalamus),
100 μm (spinal dorsal horn) and 50 μm (dorsal root ganglia).
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for NR2B subunit, EPSCs were further decreased by 21.6
± 3.7% (n = 7) in wild-type and by 22.5 ± 4.8% (n = 7)
in TgDREAM mice (Figure 4B). These results indicate
that both NR2A and NR2B-containing NMDA receptors
were impaired in transgenic CA1 hippocampal neurons.
Normal expression and phosphorylation of NMDA
receptor subunits in TgDREAM mice
The reduced NMDA EPSCs may be due to the altered
expression or phosphorylation of NMDA receptor subu-
nits. Using Western blot, we found no difference in the
expression of NMDA receptor protein subunits, NR1,
NR2A or NR2B, in wild-type and TgDREAM mice (Fig-
ure 5A), suggesting that the genes encoding these subu-
nits are not targets for DREAM repression. Moreover,
we found that the levels of PSD-95 protein, a well-char-
acterized NMDA receptor interacting protein, were
similar in TgDREAM and wild-type mice (Figure 5A).
Phosphorylation of NMDA receptors is important for
their synaptic functions [47,48]. We next wanted to
know whether the phosphorylation of NMDA receptors
was modified in TgDREAM hippocampus. To address
this question, we studied total phosphorylation of
NMDA receptor subunits in wild-type and TgDREAM
mice. We found no change in the phosphorylation of
NMDA receptor subunits NR1, NR2A or NR2B in
TgDREAM mice (Figure 5B). Taken together, our
results suggest that DREAM is not directly involved in
the regulation of NMDA receptor expression or
phosphorylation.
DREAM interacts with PSD-95
Since DREAM nuclear repressor activity appears not to
be responsible for the decrease in NMDA receptor func-
tion, we next investigated whether DREAM could
directly interact with NMDA receptor subunits or inter-
fere in the interaction of the receptor with docking pro-
teins known to participate in receptor functions. Among
them, PSD-95 is a major scaffolding protein in the post-
synaptic density, tethering NMDA receptors to signaling
proteins, and is therefore critical for NMDA receptor
function [49]. Co-immunoprecipitation experiments
using a monoclonal antibody specific for DREAM
showed that DREAM is associated with PSD-95 in hip-
pocampal extracts from wild-type mice (Figure 6A). In
parallel experiments, we did not observe the interaction
Figure 3 Reduction of pairing protocol-induced long-term depression in the hippocampus in TgDREAM mice. (A) Diagram showing the
paring protocol for LTP induction. The holding potential is +30 mV and 80 presynaptic stimulations at 2 Hz were applied. (B) LTP induced in
hippocampal CA1 pyramidal neurons in wild-type mice (filled circles, n = 6) and TgDREAM mice (open circles, n = 6) by pairing protocol. In the
present and following figures, the insets show averaged EPSC at 5 and 25 min after the pairing procedure (arrow). The dashed line indicates the
mean basal synaptic response. (C) Pooled data show no significant difference (n.s.) of LTP in wild-type and TgDREAM mice. (D) Diagram
showing the pairing protocol for LTD induction. The holding potential is -45 mV and 300 presynaptic stimulations at 1 Hz were applied. (E) LTD
was stably induced by pairing protocol in wild-type mice (filled circles, n = 8), but completely abolished in TgDREAM mice (open circles, n = 8).
(F) Pooled data show a significant difference in LTD between wild-type and TgDREAM mice. ** P < 0.01.
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Figure 4 Reduced NMDA receptor-mediated synaptic transmission in TgDREAM mice. (A) Input-output relationship for NMDA receptor-
mediated EPSCs evoked by various stimulation intensities in wild-type mice (filled circles, n = 8) and TgDREAM mice (open circles, n = 7). The
amplitude of NMDA receptor current in TgDREAM mice was significantly reduced compared with that in wild-type mice. * P < 0.05. The right
panel shows representative traces for NMDA receptor-mediated EPSCs in wild-type and TgDREAM mice. (B) The percentage of NR2A or NR2B
component of NMDA receptor-mediated EPSCs is similar in the TgDREAM (n = 7) and wild-type mice (n = 7). The right panel shows sample
traces of NMDAR-mediated EPSCs in control, 0.4 μM NVP-AAM077 (NVP) and 0.4 μM NVP-AAM077 + 3 μM ifenprodil (NVP + Ifen) in wild-type
and TgDREAM mice.
Figure 5 Analysis of NMDA receptor protein in the hippocampus of TgDREAM mice. (A) Representative western blot (left) and quantified
data (right) for expression levels of NR1, NR2A and NR2B subunits, and PSD-95 in hippocampus from wild-type and TgDREAM mice. Data were
normalized to expression level of wild-type mice (n = 4 for each group). (B) Representative western blot (left) and quantified data (right) for
phosphorylation of NR1, NR2A and NR2B at serine residues in hippocampus from wild-type and TgDREAM mice. Data were normalized to
expression level of wild-type mice (n = 4 for each group).
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between DREAM and the NMDA receptor subunits
NR1, NR2A or NR2B (Figure 6B). Furthermore, the role
of Ca2+ in the interaction between DREAM and PSD-95
was studied. We found that the immunoprecipitation of
PSD-95 was reduced when Ca2+ is increased (Figure
6C). Taken together, these data indicate there is a speci-
fic interaction between DREAM and PSD-95, and Ca2+
negatively regulates the interaction. The results suggest
that DREAM possibly inhibits NMDA receptor function
under basal conditions but allow receptor function nor-
mally upon membrane depolarization and calcium entry.
Normal AMPA receptor function in TgDREAM mice
To test whether the function of AMPA receptors was
altered also in TgDREAM mice, we compared the
input-output relationship of AMPA receptor-mediated
EPSCs in TgDREAM and wild-type mice. No significant
difference was found in AMPA EPSCs between the two
genotypes (Figure 7A). In addition, we studied the
expression of AMPA receptor subunits in TgDREAM
mice by using Western blot. We found that the
expression of GluR1 or GluR2&3 subunits was similar
in TgDREAM and wild-type mice (Figure 7B). Phos-
phorylation of GluR1 at Ser 831 and Ser 845 sites is
important for GluR1 trafficking [50]. However, there is
no significant difference in pGluR1 phosphorylation at
either Ser 831 or Ser 845 site in TgDREAM and wild-
type mice (Figure 7C). Therefore, the loss of LTD may
arise from impaired functions of NMDA receptor but
not AMPA receptor and the reduced NMDA receptor
function may be due to the constitutive binding of
mutant DREAM with PSD-95.
Impaired contextual fear memory in TgDREAM mice
It is believed that alterations in the strength of synaptic
connections in hippocampus underlie contextual and
spatial memories [10,51] (Table 1). Therefore, impaired
NMDA functions and LTD may lead to a deficit in fore-
brain-dependent memory in TgDREAM mice. To test
this idea, we examined contextual fear memory. We
found no significant difference in freezing responses
immediately following the shock/tone pairing between
TgDREAM and wild-type mice, suggesting that DREAM
mutation did not cause any developmental defects that
would interfere with the shock-induced freezing
responses. In contrast, TgDREAM mice showed a signif-
icant reduction in contextual memory at 1 hr, 1 and 3
days after conditioning compared to wild-type (n = 8 for
TgDREAM; n = 6 for control) (Figure 8A). Furthermore,
we tested auditory fear conditioning in TgDREAM mice
and we found that auditory fear memory in transgenic
mice (n = 8) is similar to that in wild-type mice (n = 6)
(Figure 8B). We noticed that the freezing responses are
small in both wild-type and TgDREAM mice (both are
B6CBAF1/J). This may be due to the genetic variability
since we have also tested C57BL/6J wild-type mice and
found they show normal auditory fear responses (around
70%).
To determine whether the decrease in fear memory of
TgDREAM mice is attributable to changes in pain sensi-
tivity to the footshock, we measured nociceptive
responses in the hotplate and tail-flick tests. No differ-
ence was found between tail-flick latencies of wild-type
and TgDREAM mice (wild-type, 5.5 ± 0.02 s, n = 6;
TgDREAM, 5.7 ± 0.3 s, n = 8) (Figure 8C). Similarly, no
difference was observed between nociceptive responses
of wild-type and TgDREAM mice for the hotplate set at
55°C (wild-type, 9.2 ± 1.8 s, n = 6; TgDREAM, 12.3 ±
0.5 s, n = 8) (Figure 8C).
Discussion
DREAM was identified as the first Ca2+-binding protein
that in the nucleus binds directly to DNA at specific
regulatory elements and represses transcription in a Ca2
+-dependent manner [34]. Outside the nucleus DREAM
modifies the activity of several proteins to modulate
Figure 6 DREAM interacts with PSD95 protein in vivo. (A) Co-
immunoprecipitation of DREAM with PSD-95 in mouse hippocampal
extracts from wild type mice. DREAM antibody immunoprecipitated
DREAM bound to PSD-95 (left) while the PSD-95 antibody
immunoprecipitated PSD-95 along with DREAM (right). Neither PSD-
95 nor DREAM was immunoprecipitated using a control IgG. (B)
DREAM antibody immunoprecipitated DREAM, but no NMDA
receptor subunits (NR1, NR2A or NR2B) was detected in the
immunoprecipitation. (C) PSD-95 protein was immunoprecipitated
from mouse hippocampal extracts by a specific DREAM antibody.
Increasing Ca2+ concentrations (0.1 and 0.25 mM) prevent this
interaction. Absence of Ca2+ (0) corresponds to 2 mM EDTA.
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different biological functions [32]. In the present study,
we used transgenic mice overexpressing a dominant
active Ca2+- and cAMP-insensitive mutant of DREAM
to investigate the role of DREAM in synaptic transmis-
sion and plasticity in the hippocampus as well as its
related learning behavioral responses. We showed that
there is impaired LTD in TgDREAM mice, which may
be due, at least in part, to a reduced function of NMDA
receptor by the interaction between DREAM and PSD-
95 (Figure 9). Finally, the contextual fear memory was
significantly reduced as well. Thus, our results provide
the strong evidence of DREAM involvement in regulat-
ing hippocampal NMDA receptor function, long-term
plasticity and contextual fear memory.
DREAM and hippocampal LTD
DREAM regulates the expression of several learning-
related genes[32,33]. Studies using DREAM knockout
mice, however, have reported no effect [35] or a minor
role of DREAM in hippocampal synaptic plasticity [41].
In this later study, enhanced LTP in the dentate gyrus
of DREAM knockout mice is associated with decreased
A-type current density [41]. We found that LTD but
not LTP was impaired in transgenic CA1 neurons. The
reduced synaptic LTD in TgDREAM CA1 neurons may
be due to an impaired function of NMDA receptor
rather than Kv4 channel. Our conclusion is based on
the following three lines of evidence: (1) Induction of
synaptic plasticity at hippocampal CA1 synapses
requires the activation of NMDA receptors; (2) NMDA
receptor-mediated EPSCs were reduced in TgDREAM
mice; (3) A-type current is not altered in TgDREAM
mice. Nevertheless, additional mechanisms could also
contribute to an abnormal synaptic plasticity in trans-
genic CA1 hippocampal neurons, e.g. the reduced
expression of Na+/Ca2+ exchanger-3 in TgDREAM hip-
pocampus that results in elevated intracellular levels of
free Ca2+ [43]. Since hippocampal CA1 LTP is also
NMDA receptor-dependent [21,52,53], it is puzzling
Figure 7 Normal AMPA receptor function and expression inTgDREAM mice. (A) Input-output relationship for AMPA receptor-mediated
EPSCs in wild-type (filled circles, n = 7) and TgDREAM mice (open circles, n = 7). There is no significant difference between the two groups. The
sample traces are shown in the right panel. (B) Representative western blot (left) and quantified data (right) for expression levels of GluR1 and
GluR2&3 subunits in hippocampus from wild-type and TgDREAM mice. Data were normalized to expression level of wild-type mice (n = 4 for
each group). (C) Representative western blot (left) and quantified data (right) for phosphorylation of AMPA GluR1 receptor at ser831 and 845
sites in hippocampus from wild-type and TgDREAM mice. Data were normalized to expression level of wild-type mice (n = 4 for each group).
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that LTP is normal in TgDREAM mice. Further studies
are needed to address the differential modulation of
DREAM on hippocampal LTP and LTD. Moreover, dif-
ferent types of LTD, such as metabotropic glutamate
receptor- and muscarinic acethycholine receptor-depen-
dent LTD, have been reported in the hippocampus [54]
and some of them are even Ca2+-independent LTD [55].
Whether or not DREAM is involved in these different
forms of LTD remains to be tested in future studies. In
the present study, we propose that DREAM binds with
PSD95 and thus affects NMDA receptor function and
the induction of LTD. In addition, there is other cal-
cium sensing proteins, such as hippocalcin and neuronal
calcium sensor-1, contribute to hippocampal LTD.
Furthermore, they may attribute to hippocampal LTD
by affecting the trafficking of AMPA receptor through
the interaction with clathrin adaptor protein 2 complex
and protein interacting with C kinase, respectively
[56,57].
DREAM and NMDA receptor functions
NMDA receptors are involved in excitatory synaptic
transmission and plasticity associated with a variety of
brain functions, from memory formation to chronic
pain. We found that DREAM selectively regulates
NMDA receptor function. Several possibilities might
contribute to the regulation of NMDA EPSCs by
DREAM. First, expression or phosphorylation of NMDA
receptors may be altered in TgDREAM mice. This pos-
sibility could also be excluded based on our results
showing no change in expression or phosphorylation of
any of the NMDA receptor subunits. Second, DREAM
may affect NMDA receptor function through the con-
trol of prodynorphin gene expression [34,35]. Previous
studies have revealed that dynorphin could regulate the
function of NMDA receptors by acting directly on the
receptor [58] or indirectly through k-opiate receptors
[59]. However, in our experimental conditions applica-
tion of dynorphin did not affect NMDA-induced EPSCs
in hippocampal neurons (Wu et al., unpublished data).
Third, DREAM may affect NMDA receptor function by
changing the expression or the function of scaffolding
proteins. We found that the expression of PSD-95 is not
changed in TgDREAM mice, however, co-immunopreci-
pitation experiments show that there is a direct interac-
tion between DREAM and PSD-95. Binding of PSD95
with NR2 subunit was implicated in NMDA receptor
trafficking and function on the cell membrane. There-
fore, Ca2+-insensitive TgDREAM may constitutively
interact with PSD-95 and inhibit NMDA receptor
Figure 8 Impaired contextual fear memory in TgDREAM mice.
(A) Contextual fear memory was impaired in TgDREAM mice (n =
8) compared with wild-type mice (n = 6) 1 h and 1 and 3 d after
training. *** P < 0.001. (B) No significant difference in auditory fear
conditioning between TgDREAM (n = 8) and wild-type mice (n = 6).
(C) Comparison of nociceptive responses between TgDREAM (n =
8) and wild-type mice (n = 6). There was no significant difference in
response latency between genotypes in the hotplate test (left) or in
the tail-flick reflex (right).
Table 1 Examples of genetic manipulations on hippocampal CA1 LTD and fear memory
Genetic manipulations CA1 LTP CA1 LTD Basal transmission Contextual fear memory Auditory fear memory References
TgDREAM Normal Reduced Normal Reduced Normal This study
SV40 transgenic Normal Reduced Normal Normal - [72]
Neurabin-/- Reduced Normal Enhanced Reduced Normal [68]
Shank1-/- Normal Normal Reduced Reduced Normal [76]
MeCP2308/Y Reduced Reduced Enhanced Reduced - [67]
EGR1-/- Normal Normal - Normal Reduced [77,78]
NCX2-/- Enhanced Lower
threshold
Normal Enhanced Normal [69]
CaMKIV-/- Reduced Normal Normal Reduced Reduce [23,25]
Calcineurin-/- Normal Reduced Normal Normal Normal [71]
NMDA NR2B overexpression Enhanced Normal Normal Enhanced Enhanced [70]
PKCg-/- Reduced Normal Normal Reduced Normal [65,66]
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trafficking or there is an impaired recruitment of
TgDREAM-bound PSD-95 to synaptic protein com-
plexes needed for NMDA receptor function. Future stu-
dies are needed to explore the molecular mechanisms
underlying the interaction between DREAM and PSD95
and how this interaction affects NMDA receptor
function.
Hippocampal LTD and fear memory
Since the role of the hippocampus is well established in
the context-related memory formation, this experimen-
tal paradigm has been commonly used for measuring
behavioral consequences of molecular changes in hippo-
campal circuits [10,51,60-64]. A variety of studies have
shown that LTP in hippocampal CA1 neurons is corre-
lated with contextual fear memory (Table 1). For exam-
ple, reduced CA1 LTP is selectively associated with
impaired contextual but not auditory fear memory in
PKCg knockout mice, CaMKIV knockout mice,
MeCP2308/Y transgenic mice and neurabin knockout
mice [23,25,65-68], while enhanced CA1 LTP is also
associated with enhanced contextual fear response in
mice overexpressing NMDA NR2B or lacking Na+/Ca2+
exchanger 2 [69,70]. In most of these cases, hippocam-
pal LTD was not affected in these mutant mice. In mice
lacking calcineurin or with expression of small t antigen
of simian virus 40 inhibiting PP2A, LTD is selectively
reduced. Interestingly, these mice show normal contex-
tual fear memory but impaired working memory [71,72].
In the present study, we found that hippocampal CA1
LTD was significantly reduced in TgDREAM mice while
hippocampal LTP was not affected. In parallel, beha-
vioral contextual memory was significantly reduced,
while auditory fear memory was not affected. In addi-
tion, our preliminary data using Morris water maze test
also indicated the impaired spatial memory in
TgDREAM mice (Mellström et al., submitted). These
results provide the evidence linking hippocampal CA1
LTD with contextual fear memory. We propose that
both LTP and LTD are critical for the formation of con-
textual fear memory, and deficits in either of them will
directly or indirectly impair the memory formation.
Materials and methods
Animals
Transgenic mice overexpressing a Ca2+ insensitive
DREAM mutant (line 33) with specific dominant active
function over DRE-mediated transcription have been
previously described [43,44]. Wild-type and transgenic
Figure 9 Simplified model of the novel function of DREAM in NMDA receptor-mediated signaling transduction at synapses. At
postsynaptic sites, DREAM interacts with PSD-95, and inhibits the functions of NMDA receptors. Binding of Ca2+ to DREAM releases the
interaction between DREAM and PSD95. In TgDREAM mice, Ca2+-insensitive mutant DREAM may constitutively bind to PSD95, leading to the
impaired recruitment of PSD-95 and reduced NMDA receptor function. The loss of LTD in TgDREAM mice is likely due to the impaired function
of NMDA receptors. Within the nucleus, it is known that DREAM binds to DRE located downstream from the transcriptional start site, and inhibits
the promoter activity. The binding of Ca2+ to DREAM releases this inhibition, leading to higher levels of transcription.
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mice were housed under a 12 h light/dark cycle with
food and water ad libitum. The Animal Care and Use
Committee at the University of Toronto approved the
experimental protocols.
Whole-cell patch clamp recording
Coronal brain slices (300 μm) from 6- to 8-week-old
C57BL/6 and TgDREAM mice containing hippocampus
were prepared using standard methods [68]. Slices were
transferred to a submerged recovery chamber with oxy-
genated (95% O2 and 5% CO2) artificial cerebrospinal
fluid (ACSF) containing the following (in mM): 124
NaCl, 2.5 KCl, 2 CaCl2, 2 MgSO4, 25 NaHCO3, 1
NaH2PO4, and 10 glucose, at room temperature for at
least 1 h before electrophysiological experiments.
Experiments were performed in a recording chamber on
the stage of an Olympus BX51WI microscope (Tokyo,
Japan) with infrared DIC optics for visualization of
whole-cell patch clamp recordings. Excitatory postsy-
naptic currents (EPSCs) were recorded from hippocam-
pal CA1 pyramidal neurons with an Axon 200B
amplifier (Molecular devices, CA) and the stimulations
were delivered by a bipolar tungsten stimulating elec-
trode placed in stratum radium. EPSCs were induced by
repetitive stimulations at 0.02 Hz, and neurons were vol-
tage clamped at -70 mV. Picrotoxin (100 μM) was
always present to block GABAA receptor-mediated inhi-
bitory synaptic currents. The recording pipettes (3-5
MΩ) were filled with solution containing (in mM):145
K-gluconate, 5 NaCl, 1 MgCl2, 0.2 EGTA, 10 HEPES, 2
Mg-ATP, and 0.1 Na3-GTP (adjusted to pH 7.2 with
KOH). When current-voltage relationship experiments
and NMDA receptor-mediated EPSCs were recorded, K-
gluconate was replaced by equomolar CsMeSO3 and 5
mM QX-314 chloride in the pipette solution. The
NMDA EPSCs were recorded at the holding potential of
-10 mV in the presence of CNQX (20 μM). NMDA
EPSCs were evoked at 0.05 Hz. After obtaining stable
EPSCs for at least 10 min, LTP was induce by 300
pulses at 2 Hz paired with postsynaptic depolarization
at +30 mV, while LTD was induced by 300 pulses at 1
Hz paired with postsynaptic depolarization at -45 mV
[73,74]. Throughout the experiment, the series resis-
tance was continuously monitored and data were dis-
carded if series resistance changed by more than 15%
during experiments.
Western blot
Hippocampal tissues were dissected and homogenized in
lysis buffer (10 mM Tris-HCl, pH 7.4, 2 mM EDTA, 1%
SDS) containing 1× protease inhibitor cocktail (Sigma,
MO) and 1× phosphatase inhibitor cocktail 1 and 2
(Sigma, MO). Western blot analysis was carried out as
described [75]. Briefly, protein samples were separated
on SDS-polyacrylamide gels and transferred to polyviny-
lidene fluoride membranes at 4°C. Membranes were
probed with 1:3000 dilution of anti-GluR1 (Upstate,
NY), anti-GluR2&3 (Chemicon, CA), 1:2000 dilution of
anti-PSD-95 (Chemicon, CA), 1:1000 dilution of anti-
phospho-GluR1 Ser845 (Upstate, NY) or anti-phospho-
GluR1 Ser831 (Upstate, NY), and 1:1000 dilution of
anti-NR1 (Upstate, NY) anti-NR2A (Chemicon), or anti-
NR2B (Chemicon) antibodies. The membranes were
incubated in the appropriate horseradish peroxidase-
coupled secondary antibody for 1 h followed by
enhanced chemiluminescence (ECL) detection of the
proteins with Western Lightning Chemiluminescence
Reagent Plus (Perkin Elmer Life Sciences, MA) accord-
ing to the manufacturer’s instructions. To verify equal
loading, membranes were also probed with 1:3000 dilu-
tion of anti-actin antibody (Sigma, MO). The density of
immunoblots was measured using the NIH ImageJ
software.
Quantitative real-time RT-PCR
RNA was isolated from hippocampal tissues using TRI-
zol (Invitrogene), treated with DNAse (Ambion) and
reverse transcribed using hexamer primers and Moloney
murine leukemia virus reverse transcriptase (Invitro-
gene). To confirm the absence of genomic DNA, each
sample was processed in parallel without reverse tran-
scriptase. Quantitative real-time PCR for TgDREAM
was performed using the primers: forward 5’-CACC-
TATGCACACTTCCTCTTCA-3’ and reverse 5’-ACCA-
CAAAGTCCTCAAAGTGGAT-3’ and the TaqMan
MGB probe VIC-5’-CGCCTTTGCTGCGGC-3’-MGB,
specific for TgDREAM. The results were normalized by
quantification of b-actin mRNA using specific primers
and TaqMan MGB probe supplied by Applied-
Biosystems.
Immunohistochemistry
Animals (n = 6) were overdosed with sodium pentobar-
bital and perfused transcardially with 20 ml of 0.1 M
phosphate buffered saline (PBS; pH = 7.4) and 4% paraf-
ormaldehyde in PBS. Brains were then dissected out,
cryoprotected in 30% sucrose, included in embedding
medium (Tissue-Tek; Sakura Finetek, Torrance, CA),
fast-frozen in dry-ice, cut coronally on a cryostat (20
μm), thaw-mounted on glass slides and allowed to dry
overnight. Sections were re-hydrated by incubation in
alcohol solutions of decreasing concentrations (100, 95,
70, 50%; 2 mins each) and placed in distilled water for 5
mins. Next, sections were placed in a 0.5% Cresyl violet
solution for 5 mins, dehydrated in a series of alcohols,
defatted in xylenes and coverslipped.
Immunoprecipitation
To detect NMDA receptor subunit phosphorylation,
solubilized protein samples were prepared with modified
RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40,
0.25% Na-deoxycholate, 150 mM NaCl, 1 mM EDTA, 1
mM PMSF), and precipitated with 50 μl of protein G-
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agarose pre-coupled with anti-phosphoserine (BD Bios-
ciences, Franklin Lakes, NJ) for 4 h at 4°C. The reaction
mixtures were then washed three times and eluted by
boiling in loading buffer, and were subjected to western
blot using the antibodies to NMDA receptor subunits.
The interaction between DREAM and PSD-95 was
shown by coimmunoprecipitation from hippocampal tis-
sue, homogenized and lysed by in buffer: Tris pH 7.5,
50 mM; NaCl 150 mM; NP40 1%; Na-deoxycholate
0.25%; protease inhibitor cocktail. Cleared extracts were
supplemented with EDTA, 2 mM or with CaCl2, 0.1 and
0.25 mM final concentrations. Five μg of a specific anti-
body for DREAM was used for immunoprecipitation
and immuncomplexes were captured using protein A-
coupled magnetic beads (Ademtech). Samples without
specific antibody were used as control washed beads
were eluted and subjected to western blot using anti-
PSD-95 (clone 7E3-1B8, Affinity BioReagents) 1/2000.
Fear conditioning
Fear conditioning was performed in an isolated shock
chamber (Med Associates, St. Albans, VT). Freezing
responses (total immobility aside from respiration) were
manually scored every 10 s. The conditioned stimulus
(CS) was an 85 dB sound at 2,800 Hz for 30 s, and the
unconditioned stimulus (US) was a continuous
scrambled foot shock at 0.75 mA for 2 s. During train-
ing, after 2 min of habituation, mice were presented
with a 30 s tone (CS) and a shock (US) beginning at 28
s after the onset of CS. After CS/US pairing (three tone-
shock pairings were delivered at 30 s intervals), the mice
remained in the chamber for an additional 30 s to mea-
sure immediate freezing. At 1 h, 1 and 3 d after training,
each mouse was placed back into the shock chamber to
test retention, and the freezing response was recorded
for 3 min (contextual conditioning). Subsequently, the
mice were placed in a novel chamber and monitored for
3 min before the onset of the tone identical to the CS
was delivered for 3 min, and the freezing response was
recorded (auditory conditioning).
Behavioral sensory responses to noxious stimuli
The spinal nociceptive tail-flick reflex was evoked by
focused, radiant heat (Columbus Instruments, Colum-
bus, Ohio) provided by a 50 W projector lamp focused
on a 1.5 × 10 mm area on the underside of the tail. The
cutoff time of 10 seconds was used to minimize damage
to the skin of the tail. The hotplate consisted of a ther-
mally controlled 10-inch × 10-inch metal plate (55°C)
surrounded by four Plexiglass walls (Columbus Instru-
ments, Columbus, Ohio). The cutoff time of 30 seconds
was imposed to prevent tissue damage. All behavioral
tests were performed at 10 min intervals. The baseline
response latency was an average of three or four
measurements.
Data analysis
Results were expressed as mean ± SEM. Statistical com-
parisons were performed using one- or two-way
ANOVA using the Student-Newman-Keuls test for post
hoc comparisons.
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